The H1 haplotype of the tau cene (MAPT) is associated with mild cognitive impairment

Journal of Alzheimer's Disease

Volumn 19, Issue 3, 2010, Pages 909-914

  Di Maria, Emilio ^a,b   Cammarata, Sergio ^b   Parodi, Maria Isola ^b   Borghi, Roberta ^c   Benussi, Luisa ^d   Galli, Marialaura ^b   Galimberti, Daniela ^e   Ghidoni, Roberta ^d   Gonella, Davide ^c   Novello, Cristina ^b   Pollero, Valeria ^b   Perroni, Lucia ^b   Odetti, Patrizio ^c   Scarpini, Elio ^e   Binetti, Giuliano ^d   Tabaton, Massimo ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; APOP; Association study; MAPT; Mild cognitive impairment; Tau protein

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN;

AGED; ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL;

EID: 77149123320     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1285     Document Type: Article

References (23)

1. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58, 1985-1992.
2. Myers AJ, Kaleem M, Marlowe L, Pittman AM, Lees AJ, Fung HC, Duckworth J, Leung D, Gibson A, Morris CM, de Silva R, Hardy J (2005) The H1c haplotype at the MAPTlocus is associated with Alzheimer's disease. Hum Mol Genet 14, 2399-2404. (Pubitemid 41418001)
3. Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van D, V, de Silva R, Hardy J (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25, 561-570.
4. Ginsberg SD, Che S, Counts SE, Mufson EJ (2006) Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Neurochem 96, 1401-1408.
5. Bu G(2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10, 333-344.
6. Brouwers N, Sleegers K, Van BC (2008) Molecular genetics of Alzheimer's disease: an update. Ann Med 40, 562-583.
7. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST (2001) Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56, 1133-1142.
8. Assini A, Cammarata S, Vitali A, Colucci M, Giliberto L, Borghi R, Inglese ML, Volpe S, Ratto S, Dagna-Bricarelli F, Baldo C, Argusti A, Odetti P, Piccini A, Tabaton M (2004) Plasma levels of amyloid protein 42 are increased in women with mild cognitive impairment. Neurology 63, 828-831.
9. Quesada JJ, Ferrucci L, Calvani D,Valente C, Salani B, Bavazzano A(1997) Formal education as an effect modifier of the relationship between Mini-Mental State Examination score and IADLs disability in the older population. Aging 9, 175-179.
10. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17, 37-49.
11. Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, Marlowe L, Duckworth J, Leung D, Williams D, Kilford L, Thomas N, Morris CM, Dickson D, Wood NW, Hardy J, Lees AJ, de Silva R (2005) Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet 42, 837-846.
12. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19, 149.
13. Excoffier L and Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12, 921-927.
14. Excoffier L, Laval G, Schneider S (2005) Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinform Online 1, 47-50.
15. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing en dogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
16. Abraham R, Sims R, Carroll L, Hollingworth P, O'Donovan MC, Williams J, Owen MJ (2009) An association study of common variation at the MAPT locus with late-onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 150B, 1152-1155.
17. Barabash A, Marcos A, Anćin I, V́azquez-Alvarez B, de Ugarte C, Gil P, Ferńandez C, Encinas M, Ĺopez-Ibor JJ, Cabranes JA (2009) APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 30, 1254-1264.
18. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L,Wallin AK, Hampel H, Burger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K(2009) Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 8, 619-627.
19. LautenschlagerNT, Flicker L,Vasikaran S, Leedman P, Almeida OP (2005) Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia. Am J Geriatr Psychiatry 13, 731-734.
20. Katzman R, ZhangMY, Chen PJ,GuN, Jiang S, Saitoh T, Chen X, Klauber M, Thomas RG, Liu WT, Yu ES (1997) Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of Dementia. Neurology 49, 779-785.
21. Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Stopford C, Julien C, Thompson J, Payton A, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM (2009) Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord 23, 60-66.
22. Ramakers IH, Visser PJ, Aalten P, Bekers O, Sleegers K, van Broeckhoven CL, Jolles J, Verhey FR (2008) The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology. Dement Geriatr Cogn Disord 26, 101-108.
23. Altshuler D, Daly MJ, Lander ES (2008) Genetic mapping in human disease. Science 322, 881-888.